Trial Profile
Effect of chemotherapy plus bevacizumab in patients with metastatic colorectal cancer.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Oct 2015
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary)
- Indications Colorectal cancer
- Focus Therapeutic Use
- Acronyms BRiTE